I. Fleming et al., CA2-INDEPENDENT ACTIVATION OF THE ENDOTHELIAL NITRIC-OXIDE SYNTHASE IN RESPONSE TO TYROSINE PHOSPHATASE INHIBITORS AND FLUID SHEAR-STRESS(), Circulation research, 82(6), 1998, pp. 686-695
Fluid shear stress enhances NO formation via a Ca2+-independent tyrosi
ne kinase inhibitor-sensitive pathway, In the present study, we invest
igated the effects of the protein tyrosine phosphatase inhibitor pheny
larsine oxide and of fluid shear stress on endothelial NO production a
s well as on the membrane association and phosphorylation of the NO sy
nthase (NOS) III, Phenylarsine oxide (IO mu mol/L) induced an immediat
e and maintained NO-mediated relaxation of isolated rabbit carotid art
eries, which was insensitive to the removal of extracellular Ca2+ and
the calmodulin antagonist calmidazolium. This phenylarsine oxide-induc
ed vasodilatation was unaffected by genistein but abrogated by the tyr
osine kinase inhibitor erbstatin A, Incubation of native or cultured e
ndothelial cells with phenylarsine oxide resulted in a time-dependent
tyrosine phosphorylation of mainly Triton X-100-insoluble (cytoskeleta
l) proteins, along with a parallel change in the detergent solubility
of NOS III, such that the enzyme was recovered in the cytoskeletal fra
ction. A similar, though slightly delayed, phenomenon was also observe
d after the application of fluid shear stress but not in response to a
ny receptor-dependent agonist. Although Ca2+-independent NO formation
was sensitive to erbstatin A, phenylarsine oxide treatment was associa
ted with the tyrosine dephosphorylation of NOS III rather than its hyp
erphosphorylation. Proteins that also underwent redistribution in resp
onse to the tyrosine phosphatase inhibitor included paxillin, phosphol
ipase C-gamma(1), mitogen-activated protein kinase, and the tyrosine k
inases Src and Fyn. We envisage that, fluid shear stress and tyrosine
phosphatase inhibitors may alter the conformation and/or protein coupl
ing of NOS III, facilitating its interaction with specific phospholipi
ds, proteins, and/or protein kinases that enhance/maintain its Ca2+-in
dependent activation.